1. Alon, R., Aker, M., Feigelson, S., Sokolovsky-Eisenberg, M., Staunton, D.E., Cinamon, G., Grabovsky, V., Shamri, R. and Etzioni, A. (2003) A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 101, 4437–4445.
2. Alon, R. and Etzioni, A. (2003) LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 24, 561–566.
3. Anderson, D.C. and Smith, C.W. (2001). Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. New York, McGraw-Hill.
4. Bauer, T.R., Jr., Hai, M., Tuschong, L.M., Burkholder, T.H., Gu, Y.C., Sokolic, R.A., Ferguson, C., Dunbar, C.E. and Hickstein, D.D. (2006) Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy. Blood 108, 3313–3320.
5. Bauer, T.R., Jr. and Hickstein, D.D. (2000) Gene therapy for leukocyte adhesion deficiency. Curr. Opin. Mol. Ther. 2, 383–388.